Absence of CTL responses to early viral antigens facilitates viral persistence

Journal of Immunology

Volumn 180, Issue 5, 2008, Pages 3113-3121

  Schildknecht, Anita ^a,b   Welti, Sarah ^a   Geuking, Markus B ^a,c   Hangartner, Lars ^a,d   Van Den Broek, Maries ^a,b  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c MCMASTER UNIVERSITY   (Canada)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN; VIRUS ANTIGEN; VIRUS NUCLEOPROTEIN; NUCLEOPROTEIN; NUCLEOPROTEIN PEPTIDE 118 126, LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NUCLEOPROTEIN PEPTIDE 118-126, LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NUCLEOPROTEIN PEPTIDE 394 408, LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NUCLEOPROTEIN PEPTIDE 394-408, LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE SEVERITY; IMMUNE RESPONSE; IMMUNITY; INOCULATION; KINETICS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS LOAD; VIRUS MENINGITIS; ANIMAL; C57BL MOUSE; CYTOTOXICITY; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; TRANSGENIC MOUSE; TUMOR CELL LINE; VIROLOGY;

ANIMALS; ANTIGENS, VIRAL; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; IMMUNE TOLERANCE; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NUCLEOPROTEINS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD;

EID: 49149084519     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.5.3113     Document Type: Article

References (35)

1. Hombach, J., H. Pircher, S. Tonegawa, and R. M. Zinkernagel. 1995. Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus protein. J. Exp. Med. 182: 1615-1619.
2. Oldstone, M. B. 2002. Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr. Top. Microbiol. Immunol. 263: 83-117.
3. Zinkernagel, R. M. 2002. Lymphocytic choriomeningitis virus and immunology. Curr. Top. Microbiol. Immunol. 263: 1-5.
4. Neuman, B. W., B. D. Adair, J. W. Burns, R. A. Milligan, M. J. Buchmeier, and M. Yeager. 2005. Complementarity in the supramolecular design of arenaviruses and retroviruses revealed by electron cryomicroscopy and image analysis. J. Virol. 79: 3822-3830.
5. Cole, G. A., N. Nathanson, and R. A. Prendergast. 1972. Requirement for θ-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature 238: 335-337.
6. + T lymphocytes mediate clearance of virus and regulate the antiviral antibody response. J. Virol. 61: 1867-1874.
7. Zinkernagel, R. M., C. J. Pfau, H. Hengartner, and A. Althage. 1985. Susceptibility to murine lymphocytic choriomeningitis maps to class I MHC genes - a model for MHC/disease associations. Nature 316: 814-817.
8. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369: 31-37.
9. Bruns, M., J. Cihak, G. Muller, and F. Lehmann-Grube. 1983. Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization. Virology 130: 247-251.
10. Buchmeier, M. J., R. M. Welsh, F. J. Dutko, and M. B. Oldstone. 1980. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30: 275-331.
11. + T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus. J. Virol. 81: 4928-4940.
12. Probst, H. C., K. Tschannen, A. Gallimore, M. Martinic, M. Basler, T. Dumrese, E. Jones, and M. F. van den Broek. 2003. Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J. Immunol. 171: 5415-5422.
13. Moskophidis, D., F. Lechner, H. Pircher, and R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362: 758-761.
14. Zajac, A. J., J. N. Blattman, K. Murali-Krishna, D. J. Sourdive, M. Suresh, J. D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188: 2205-2213.
15. Bruns, M., T. Kratzberg, W. Zeller, and F. Lehmann-Grube. 1990. Mode of replication of lymphocytic choriomeningitis virus in persistently infected cultivated mouse L cells. Virology 177: 615-624.
16. Ludin, B., T. Doll, R. Meili, S. Kaech, and A. Matus. 1996. Application of novel vectors for GFP-tagging of proteins to study microtubule-associated proteins. Gene 173: 107-111.
17. Sauer, B. 1993. Manipulation of transgenes by site-specific recombination: use of Cre recombinase. Methods Enzymol. 225: 890-900.
18. Thyagarajan, B., M. J. Guimaraes, A. C. Groth, and M. P. Calos. 2000. Mammalian genomes contain active recombinase recognition sites. Gene 244: 47-54.
19. Oehen, S. U., P. S. Ohashi, K. Burki, H. Hengartner, R. M. Zinkernagel, and P. Aichele. 1994. Escape of thymocytes and mature T cells from clonal deletion due to limiting tolerogen expression levels. Cell. Immunol. 158: 342-352.
20. Schwenk, F., U. Baron, and K. Rajewsky. 1995. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23: 5080-5081.
21. Beyer, W. R., H. Miletic, W. Ostertag, and D. von Laer. 2001. Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference. J. Virol. 75: 1061-1064.
22. Hany, M., S. Oehen, M. Schulz, H. Hengartner, M. Mackett, D. H. Bishop, H. Overton, and R. M. Zinkernagel. 1989. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Eur. J. Immunol. 19: 417-424.
23. Ludewig, B., S. Ehl, U. Karrer, B. Odermatt, H. Hengartner, and R. M. Zinkernagel. 1998. Dendritic cells efficiently induce protective antiviral immunity. J. Virol. 72: 3812-3818.
24. Battegay, M., S. Cooper, A. Althage, J. Banziger, H. Hengartner, and R. M. Zinkernagel. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J. Virol. Methods 33: 191-198.
25. 51Cr-release assay? J. Exp. Med. 164: 1075-1092.
26. + T cell responses by pathogens typically depends on CD70-mediated interactions with dendritic cells. Eur. J. Immunol. 37: 716-728.
27. Gallimore, A., A. Glithero, A. Godkin, A. C. Tissot, A. Pluckthun, T. Elliott, H. Hengartner, and R. Zinkernagel. 1998. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187: 1383-1393.
28. Roth-Cross, J. K., L. Martinez-Sobrido, E. P. Scott, A. Garcia-Sastre, and S. R. Weiss. 2007. Inhibition of the IFN-α/β Response by mouse hepatitis virus (MHV) at multiple levels. J. Virol. 81: 7189-7199.
29. Yanai, H., T. Kobayashi, Y. Hayashi, Y. Watanabe, N. Ohtaki, G. Zhang, J. C. de la Torre, K. Ikuta, and K. Tomonaga. 2006. A methionine-rich domain mediates CRM1-dependent nuclear export activity of Borna disease virus phosphoprotein. J. Virol. 80: 1121-1129.
30. Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921.
31. Geretti, A. M., and A. D. Osterhaus. 2001. Virus replication and evolution drive the kinetics and specificity of SIV-specific cytotoxic T lymphocytes. Immunol. Rev. 183: 109-114.
32. van Baalen, C. A., O. Pontesilli, R. C. Huisman, A. M. Geretti, M. R. Klein, F. de Wolf, F. Miedema, R. A. Gruters, and A. D. Osterhaus. 1997. Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS. J. Gen. Virol. 78(Pt. 8): 1913-1918.
33. Addo, M. M., M. Altfeld, E. S. Rosenberg, R. L. Eldridge, M. N. Philips, K. Habeeb, A. Khatri, C. Brander, G. K. Robbins, G. P. Mazzara, et al. 2001. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals. Proc. Natl. Acad. Sci. USA 98: 1781-1786.
34. Novitsky, V., N. Rybak, M. F. McLane, P. Gilbert, P. Chigwedere, I. Klein, S. Gaolekwe, S. Y. Chang, T. Peter, I. Thior, et al. 2001. Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific ELISPOT-based cytotoxic T-lymphocyte responses for AIDS vaccine design. J. Virol. 75: 9210-9228.
35. Bunde, T., A. Kirchner, B. Hoffmeister, D. Habedank, R. Hetzer, G. Cherepnev, S. Proesch, P. Reinke, H. D. Volk, H. Lehmkuhl, and F. Kern. 2005. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J. Exp. Med. 201: 1031-1036.